Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jamal Bamoulid, Oliver Staeck, Fabian Halleck, Michael Dürr, Alexander Paliege, Nils Lachmann, Susanne Brakemeier, Lutz Liefeldt & Klemens Budde. (2015) Advances in pharmacotherapy to treat kidney transplant rejection. Expert Opinion on Pharmacotherapy 16:11, pages 1627-1648.
Read now
Read now
Gorden Muduma, Jane Shaw, Warren M Hart, Abayomi Odeyemi & Isaac Odeyemi. (2014) Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales. Patient Preference and Adherence 8, pages 1537-1546.
Read now
Read now
Articles from other publishers (3)
Mohamed Adel Bakr, Ayman Maher Nagib, Mohamed Hamed Abbas & Ahmed Farouk Donia. (2019) Conversion From Twice-Daily to Once-Daily Tacrolimus Among Egyptian Living-Donor Kidney Allograft Recipients: A Single-Center Experience. Experimental and Clinical Transplantation 17:5, pages 594-598.
Crossref
Crossref
Tracey Jones-Hughes, Tristan Snowsill, Marcela Haasova, Helen Coelho, Louise Crathorne, Chris Cooper, Ruben Mujica-Mota, Jaime Peters, Jo Varley-Campbell, Nicola Huxley, Jason Moore, Matt Allwood, Jenny Lowe, Chris Hyde, Martin Hoyle, Mary Bond & Rob Anderson. (2016) Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. Health Technology Assessment 20:62, pages 1-594.
Crossref
Crossref
Neha Patel, Abigail Cook, Elizabeth Greenhalgh, Megan A Rech, Joshua Rusinak & Lynley Heinrich. (2016) Overview of extended release tacrolimus in solid organ transplantation. World Journal of Transplantation 6:1, pages 144.
Crossref
Crossref